-
公开(公告)号:EP0934430A1
公开(公告)日:1999-08-11
申请号:EP97912018.0
申请日:1997-09-25
发明人: DEBATIN, Klaus-Michael , LOS, Marek , HUG, Hubert
IPC分类号: C12Q1
CPC分类号: C12Q1/37 , G01N2333/96466
摘要: The invention relates to a method for apoptosis diagnosis in cells wherein the cells are loaded with a substrate for ICE/Ced3 family proteases and the protease reaction of the substrate is monitored by imaging methods. The invention also concerns a kit in order to carry out this method.
-
52.
公开(公告)号:EP3923997A1
公开(公告)日:2021-12-22
申请号:EP20703784.7
申请日:2020-02-14
-
53.
公开(公告)号:EP3676284A1
公开(公告)日:2020-07-08
申请号:EP18759329.8
申请日:2018-08-29
发明人: SCHMIDT, Patrick , UHRIG-SCHMIDT, Silke , ZÖRNIG, Inka , DOLL, Krysten , MÜLLER, Oliver , JÄGER, Dirk
IPC分类号: C07K14/005
-
54.
公开(公告)号:EP2273923B1
公开(公告)日:2020-02-26
申请号:EP09733566.5
申请日:2009-04-14
-
公开(公告)号:EP3609542A1
公开(公告)日:2020-02-19
申请号:EP18716286.2
申请日:2018-04-11
发明人: GRIMM, Dirk , BÖRNER, Kathleen
-
公开(公告)号:EP3209336B1
公开(公告)日:2019-12-11
申请号:EP15783953.1
申请日:2015-09-30
发明人: KOPKA, Klaus , BENESOVA, Martina , CARDINALE, Jens , EDER, Matthias , SCHÄFER, Martin , BAUDER-WÜST, Ulrike , HABERKORN, MICHAEL , EISENHUT, Michael
IPC分类号: A61K51/06
-
57.
公开(公告)号:EP3522866A1
公开(公告)日:2019-08-14
申请号:EP17780998.5
申请日:2017-09-19
发明人: UHL, Philipp , MIER, Walter , HABERKORN, Uwe , SAUTER, Max
-
-
公开(公告)号:EP2723269B1
公开(公告)日:2019-06-26
申请号:EP12743064.3
申请日:2012-04-23
发明人: MERSCHER, Michael , GUNDLING, Ralf , SCHWARZ, Markus , HESSER, Juergen , POTT, Peter, P. , BOESECKE, Robert , BRODERSEN, Jens , VIEIRA, Vitor , LISIAK, Eugen , NGUYEN, Am Tuong
IPC分类号: A61B34/30
-
60.
公开(公告)号:EP3417291A1
公开(公告)日:2018-12-26
申请号:EP17705868.2
申请日:2017-02-16
IPC分类号: G01N33/564 , G01N33/68
摘要: The invention relates to a method for diagnosis of an autoimmune disease in a subject wherein, presence or absence of an anti-CXC chemokine receptor (CXCR) antibody is detected in a sample from the subject diagnosed, and wherein the presence of an anti-CXCR antibody is indicative of the disease. The invention further relates to the use of (auto)antibodies against the C-X-C chemokine receptor type 3 (CXCR3) as a prognostic marker in subjects with acute graft-versus-host disease (GVHD), particularly in subjects with high grade acute GVHD. The invention also relates to the use of C-X-C chemokines selected from the group consisting of CXCL4, CXCL9, CXCL10 and CXCL11, preferably CXCL9, as a prognostic marker in subjects with acute GVHD, particularly in subjects with high grade acute GVHD.
-
-
-
-
-
-
-
-
-